S chizophrenia is a devastating disease affecting 1% of the adult population worldwide. It is a highly heritable 1 neurodevelopmental disorder 2 characterized by positive symptoms (for example, hallucinations and delusions), negative symptoms (for example, apathy and anhedonia) and cognitive symptoms (for example, impairments of memory, executive functions and attention) 3 . Cognitive and negative symptoms persist even with antipsychotic treatment 4 , preventing normal functioning of subjects. Given that schizophrenia is the seventh most costly medical disorder in our society, it is imperative to unravel its pathogenic mechanisms to develop new and efficacious treatments.
S chizophrenia is a devastating disease affecting 1% of the adult population worldwide. It is a highly heritable 1 neurodevelopmental disorder 2 characterized by positive symptoms (for example, hallucinations and delusions), negative symptoms (for example, apathy and anhedonia) and cognitive symptoms (for example, impairments of memory, executive functions and attention) 3 . Cognitive and negative symptoms persist even with antipsychotic treatment 4 , preventing normal functioning of subjects. Given that schizophrenia is the seventh most costly medical disorder in our society, it is imperative to unravel its pathogenic mechanisms to develop new and efficacious treatments.
So far, a large genome-wide association study of schizophrenia has identified 108 risk loci with genome-wide significance 5 , opening the way to a deeper understanding of schizophrenia pathogenic mechanisms. However, deciphering how these risk loci affect gene expression and result in schizophrenia pathogenesis is not a trivial task. Recent studies have made progress in this regard and shown correlations between risk locus genotypes and gene expression levels (for example, FURIN and C4A) 6, 7 . However, whether the observed manner of gene expression changes cause schizophreniarelevant neuroanatomic and behavioral deficits in animal models needs to be determined. One caveat of current expression quantitative trait loci (eQTL) studies is that most of the attempts to connect gene expression levels with risk loci are based on transcriptome studies carried out on postmortem tissues 6 , which typically involve subjects with chronic illness and years of exposure to psychotropic We generated cortical interneurons (cINs) from induced pluripotent stem cells derived from 14 healthy controls and 14 subjects with schizophrenia. Both healthy control cINs and schizophrenia cINs were authentic, fired spontaneously, received functional excitatory inputs from host neurons, and induced GABA-mediated inhibition in host neurons in vivo. However, schizophrenia cINs had dysregulated expression of protocadherin genes, which lie within documented schizophrenia loci. Mice lacking protocadherin-α showed defective arborization and synaptic density of prefrontal cortex cINs and behavioral abnormalities. Schizophrenia cINs similarly showed defects in synaptic density and arborization that were reversed by inhibitors of protein kinase C, a downstream kinase in the protocadherin pathway. These findings reveal an intrinsic abnormality in schizophrenia cINs in the absence of any circuit-driven pathology. They also demonstrate the utility of homogenous and functional populations of a relevant neuronal subtype for probing pathogenesis mechanisms during development.
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medications. Such studies cannot address pathogenic mechanisms operational during development 2 . Thus, disease-specific developmental brain tissue will be needed to unravel the role of these risk genes during critical developmental periods. Induced pluripotent stem cell (iPSC) technology 8 allows the generation of such subjectspecific developmental brain tissues with the same genetic makeup as the subject brains.
Schizophrenia modeling using iPSCs has begun 9 , and a steady stream of studies have reported schizophrenia-specific transcriptome aberrations and cellular phenotypes in iPSC-derived neural tissues 10 . It will be important to sort out causal abnormalities versus changes in effectors downstream of causal abnormalities. Correlation with genetic risk loci will provide a pathway for identifying causal abnormalities. In addition, animal model studies can help determine causal abnormalities that can recapitulate schizophrenia-like histological and behavioral abnormalities. Using iPSC-derived neural tissues for studying schizophrenia pathology is challenging because of the heterogeneity and stochasticity of iPSCderived tissues, which can lead to inconsistency due to the changing composition of neuronal subtypes within culture. Single-cell RNA sequencing (RNA-seq) can be used to address this problem. However, owing to the more limited sequencing depth inherent to single-cell RNA-seq, it is not as easy to identify differences in lowabundance genes, which could have critical roles. Thus, generation of a homogeneous and consistent population of neural subtypes is critical for successful disease modeling using iPSCs.
Cortical GABAergic interneurons (cINs) are one of the most consistently affected neuronal types in schizophrenia, especially medial ganglionic eminence (MGE)-derived cINs expressing parvalbumin (PV + ) or somatostatin (SST + ), as has been shown in many postmortem studies 11, 12 . In line with these findings, altered GABA neurotransmission in schizophrenia has been suggested to disrupt cortical gamma oscillations and thus cause cognitive deficits in subjects 13 . Accordingly, GABA A receptor agonists restore gamma band activity in schizophrenia subjects, accompanied by some degree of improved cognitive functions 14 . Furthermore, developmental cIN hypofunction leads to a schizophrenia-like phenotype, including deficits in dopaminergic systems in adult mice 15 , suggesting a role of impaired cIN development in schizophrenia pathogenesis.
In this study, we used homogeneous populations of cINs derived from iPSCs to analyze cIN-intrinsic deficits in schizophrenia and found that the protocadherin pathway is significantly altered in schizophrenia cINs early in development. cINs in the prefrontal cortex (PFC) of Pcdha knockout (KO) mice showed arborization and synaptic deficits. In line with this, knockdown (KD) of protocadherins in healthy control cINs led to significant reduction in arborization. Developmental schizophrenia cINs displayed arborization deficits in cell culture and synaptic deficits in vivo after transplantation into mouse brains. These deficits were also observed in cINs in schizophrenia postmortem PFCs. Inhibitors of protein kinase C (PKC), a downstream kinase in the protocadherin signaling pathway, normalized the arborization deficits observed in schizophrenia cINs. This study reveals intrinsic deficits in schizophrenia cINs in the absence of any circuit-mediated deficits and demonstrates the utility of iPSC-derived homogeneous neural subtypes to illuminate the mechanistic basis of schizophrenia pathogenesis and to identify potential new therapeutic targets.
Results
Generation of homogeneous populations of cINs from iPSCs.
As the first step to study the schizophrenia pathogenic mechanisms in disease-relevant developmental tissues, we generated iPSCs from healthy control and schizophrenia fibroblasts using footprint-free modified RNA methods 16 . Footprint-free reprogramming is even more important for studying schizophrenia when multiple single nucleotide polymorphisms (SNPs) with small effects work together to lead to pathogenesis. We chose Caucasian male subjects to reduce variation caused by ethnicity and gender. Furthermore, we chose subjects who required clozapine treatment to narrow down the subject group to those with more severe cases of the disease (Fig. 1a ). iPSCs reprogrammed with modified RNA transfection 16 showed human pluripotent stem cell-like morphology and expressed human pluripotent stem cell markers ( Fig. 1b) .
To obtain a homogeneous population of developmental cINs from generated iPSCs, we differentiated the iPSCs using the protocol we optimized previously 17 with a slight modification ( Fig. 1c ). This protocol generated a homogeneous population of developmental cINs from multiple iPSC lines. The homogeneity was extensively analyzed by expression of neuronal marker β -tubulin III, MGEderived cIN marker SOX6 18 , and GABA-synthesizing enzyme glutamate decarboxylase 1 (GAD1) (Fig. 1d ,e and Supplementary Fig. 1 ). Caudal ganglionic eminence (CGE)-derived cINs or non-cIN neural subtypes were observed only rarely regardless of their disease status ( Supplementary Fig. 2 ). We further analyzed the phenotypes of the generated cINs by quantitative real-time PCR (rtPCR) analysis, comparing them with undifferentiated iPSCs and induced glutamatergic neurons 19 . We observed that cIN-specific genes (GAD1, LHX6, NKX2-1 and SOX6) are highly expressed in cIN groups but not in the other cell groups. However, there was minimal expression of non-cIN markers (NANOG, PAX6, TBR1 and SLC17A7 (Vglut1)) in generated cINs ( Fig. 1f ), confirming the identity and homogeneity of the generated cells. The homogeneity of differentiated progeny is critical for the reliable transcriptome analysis of developing cINs.
Neuronal properties of cINs transplanted into mouse brains.
Previous studies on cIN induction from human PSCs have focused on human embryonic stem cell-derived cINs, and thus it was unclear whether cINs that are derived from iPSCs, which have gone through the reprogramming process from skin cells, are authentic and functional, and thus are suitable for disease modeling. To address this question, we performed extensive electrophysiological analysis after grafting these cells into mouse brains. Healthy control and schizophrenia cINs were transduced with lentivirus expressing channelrhodopsin 2 (ChR2) H134R-green fluorescent protein (GFP) fusion protein under the control of the synapsin promoter (LV-Syn-ChR2 H134R-GFP) to permit optogenetic study as well as the identification of grafted cells in brain slices. Infected cINs were then transplanted into the cerebral cortices of Nod Scid mice, followed by electrophysiological analysis 7 months after transplantation ( Fig. 2a ). In GFP + grafted cells, blue light illumination induced typical ChR2-mediated currents ( Fig. 2b ) and evoked action-potential firings ( Supplementary Fig. 3a ). The passive membrane properties of schizophrenia cINs, including membrane resistance (R m ) and membrane capacitance (C m ), were similar to those in the healthy control group ( Supplementary Fig. 3b ,c). When depolarizing voltage pulses were applied, grafted cINs showed rapidly desensitizing inward currents and sustained outward currents ( Fig. 2c ), indicating the expression of voltage-gated Na + channels and K + channels. There was no difference between groups in the voltage-dependent Na + current density ( Supplementary Fig. 3d ) and the K + current density ( Supplementary Fig. 3e ).
In current-clamp mode, the injection of depolarizing currents induced action-potential firings in all human cINs examined ( Fig. 2d ). Nonaccommodating repetitive action-potential firings were observed in > 75% of the grafted cINs in both groups, whereas grafted cells in the remaining proportion displayed single or burst action-potential firing patterns. The frequency of action-potential firings induced by current injection was comparable between groups ( Fig. 2e ) with no significant difference in afterhyperpolarization, action potential threshold and action potential half-width ( Supplementary  Fig. 3f-h) . However, the resting membrane potential of the cINs was significantly more depolarized in the schizophrenia group than in Differentiation was repeated at least three times with comparable results. e, Cell counting analysis after 8 weeks' differentiation. Data are presented as mean ± s.e.m. from three independent differentiations (n = 3 differentiations). There were no significant differences among different lines based on oneway ANOVA (β -tubulin III P = 0.2626, Sox6 P = 0.3802, and GAD1 P = 0.5072). f, rtPCR analysis of different cell types (H9 human ES cell, n = 3 batches; human iPSC, n = 6 batches from two iPSC lines; healthy control cIN, n = 9 batches from three lines; schizophrenia cIN, n = 9 batches from three lines; glutamatergic neuron, n = 6 batches from two lines). Results were normalized using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression levels and presented as mean ± s.e.m. See also Supplementary Figs. 1 and 2.
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NATure NeuroSCIeNCe the healthy control group ( Supplementary Fig. 3i ). At resting membrane potential, spontaneous action potential firings were observed in > 80% of human cINs in both groups ( Fig. 2f and Supplementary  Fig. 3j ), with comparable spontaneous action potential frequency between groups ( Supplementary Fig. 3k ), suggesting that most grafted cINs generate tonic spontaneous firings in both the schizophrenia and healthy control groups. Neuronal properties of iPSCderived cINs were also confirmed in vitro ( Supplementary Fig. 4 ).
These results demonstrate that healthy control and schizophrenia cINs develop into functional cINs whose neuronal properties are similar to those of endogenous interneurons. We next analyzed the synaptic properties of grafted human cINs to determine whether they integrate into adult brain circuitry and receive excitatory synaptic inputs from host cortical neurons. In acute cortical slices, all 26 GFP + grafted interneurons showed spontaneous excitatory postsynaptic currents (sEPSCs) at -85 mV in voltage-clamp mode (Fig. 2g ). These currents were inhibited completely by NBQX, a glutamate receptor antagonist, in all three grafted cells examined, indicating that they were mediated by the excitatory neurotransmitter glutamate. There was no significant difference in the frequency or amplitude of sEPSCs between the healthy control and schizophrenia groups ( Supplementary  Fig. 5a -c). These results suggest that human cINs from both healthy control and schizophrenia groups have functional postsynaptic machinery to receive excitatory synaptic inputs from host glutamatergic cortical neurons.
We also examined whether grafted human cINs had presynaptic mechanisms for the release of GABA, which induces inhibitory postsynaptic responses in host cortical neurons. To this end, we used optogenetic approaches to selectively stimulate grafted cINs expressing ChR2-GFP and record postsynaptic responses in GFPhost cortical neurons ( Fig. 2h ,i). Short pulses of blue light illumination induced postsynaptic currents at 0 mV in voltage-clamp mode; these currents were inhibited completely by SR95531, a GABA A receptor antagonist ( Fig. 2j ), indicating that they were mediated by inhibitory neurotransmitter GABA. Proportions of host neurons with inhibitory postsynaptic currents were comparable between groups ( Fig. 2k,l ), suggesting that the majority of recorded host neurons received inhibitory inputs from grafted cINs. The peak amplitude of inhibitory postsynaptic currents induced by photostimulation was not significantly different between groups (Fig. 2k ,l and Supplementary Fig. 5d ). Our power analysis indicates that we would need to record from 196 host neurons to achieve 80% power for detecting a 36.5 pA mean difference with standard deviation of 57.2 pA and intracluster correlation of 0.2, indicating the large sam-ple size needed to detect mild phenotypes of schizophrenia. These results demonstrate that grafted cINs have presynaptic machinery for GABA release and inhibit host cortical neurons.
PCDHA2 expression is altered in schizophrenia cINs. Given the evidence that iPSC-derived healthy control and schizophrenia cINs are authentic and fully functional interneurons, we next investigated whether there were any schizophrenia cIN-specific abnormalities in gene expression during development. We performed RNA-seq analysis, comparing transcriptomes of healthy control cINs to schizophrenia cINs after 8 weeks' differentiation. A total of 273 million reads were obtained from eight lines (four healthy control and four schizophrenia) with three independent differentiations ( Supplementary Fig. 6a ). The total number of genes were similar among different RNA-seq reactions ( Supplementary Fig. 6b ), suggesting that the read depth from each RNA-seq was sufficient to identify most of the genes expressed. When we performed a pair-wise comparison, the average r 2 value for biological replicates was ~0.95, showing high correlation that reflects the homogeneous and efficient cIN generation from iPSCs ( Supplementary  Fig. 6c ). Along the same line, the average r 2 between individuals in this study was ~0.93, as compared to ~0.82 for postmortem tissues ( Supplementary Fig. 6c ), stressing the consistency of iPSC-derived cIN samples. Principal component analysis showed that biological replicates from the same individual tend to cluster together ( Supplementary Fig. 6d ), whereas there is no clear separation based on diagnostic group, indicating the subtle nature of schizophrenia phenotype ( Supplementary Fig. 6d ,e). Neuronal markers (MAP2 and DCX) and cIN markers (GAD1, VGAT, SST and Lhx6) were highly expressed, whereas the expression of nonrelevant markers such as GFAP (astrocyte marker), MBP (oligodendrocyte marker), Vglut2 (glutamatergic neuron marker), CoupTFII (CGE-derived cIN marker), Olig2 (early MGE progenitor marker), ChAT (cholinergic neuron marker), TH (dopaminergic neuron marker) and TPH2 (serotonergic neuron marker) were low ( Fig. 3a and Supplementary Fig. 7a ). Notably, expression of those markers did not differ between healthy control and schizophrenia samples ( Fig. 3a ). Although the global gene expression pattern did not show clear separation between healthy control and schizophrenia samples, select genes did exhibit significant differences in expression between schizophrenia and healthy control samples, such as PCDHA2 ( Fig. 3b and Supplementary Fig. 6f ); this was confirmed by rtPCR analysis (Fig. 3c ).
To test whether PCDHA2 expression was also altered in other neuronal subtypes, we generated glutamatergic neurons using the Supplementary Table 3 . a, Transplantation scheme of cINs into Nod Scid mice. Eight-week-old cINs infected with LV-Syn-ChR2-GFP were transplanted into cerebral cortices. Brain slices were prepared for electrophysiological experiments 7 months after grafting (7 mo PT). b, Left: image showing ChR2-GFPexpressing grafted cINs (green) in the cerebral cortex (D, dorsal; V, ventral; M, medial; L, lateral). Right: patch-clamp recordings (Rec) were performed with grafted cells, which generated ChR2-mediated photocurrents and were labeled with biocytin-streptavidin-Alexa 568 (scale bar, 10 µ m). c, Voltage pulses from -115 mV to + 85 mV with 20-mV increments induced transient inward (Na + ) and sustained outward currents (K + ) in grafted cINs. Na + currents were quantified as peak inward currents induced by depolarization to -35 mV (red). K + currents were quantified as sustained outward currents induced by depolarization to 85 mV (blue). d, Action-potential firing induced by current injection in a grafted cell at approximately -85 mV. e, Summary plot of action-potential firings in transplanted cINs in the healthy control (15 cells) and schizophrenia groups (16 cells). Repeated measures two-way ANOVA was used for analysis (main effect of groups, P = 0.77; group × current interaction, P = 1.00). Error bars are s.e.m. f, Left: spontaneous action-potential firings recorded at resting membrane potential in a grafted cIN. Right: average action-potential firings. g, sEPSCs recorded in a grafted cell at -85 mV (left) and blocked by NBQX (right). h, Photostimulation activates ChR2-expressing grafted cINs, generating inhibitory postsynaptic currents in GFPhost neurons labeled with biocytin (red; scale bar, 10 µ m). i, Image showing a GFP + grafted human cIN (green) and a GFPhost cortical neuron labeled with biocytin (red). j, Photostimulation-induced inhibitory postsynaptic currents recorded at 0 mV in a host neuron (black) and inhibited by SR95531 (10 mM, blue). k, Inhibitory postsynaptic currents induced by photostimulation (40 mW mm -2 ) and recorded in host neurons in the healthy control (black) and schizophrenia (red) groups. l, Left: comparison of proportion of host cells with inhibitory postsynaptic currents in healthy control (15 cells of 21 cells examined) and schizophrenia groups (13 cells of 20 cells examined; P = 0.66, χ 2 test). Right: comparison of inhibitory postsynaptic current amplitude in healthy control (15 cells) and schizophrenia groups (13 cells; P = 0.37). Error bars are s.e.m. See also Supplementary Figs. 3-5. For detailed statistics information, see Supplementary Table 15 .
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Ngn2 induction protocol 19 with a slight modification ( Fig. 3d ). Glutamatergic neurons were efficiently generated from both healthy control and schizophrenia iPSCs ( Fig. 3e ). rtPCR analysis showed no significant change in PCDHA2 expression in schizophrenia glutamatergic neurons (Fig. 3f ). Further studies could reveal whether this observation applies to all developmental glutamatergic neurons or just the induced glutamatergic neurons analyzed here.
Multiple protocadherins affected in schizophrenia cINs.
Considering the heterogeneity of schizophrenia etiology, we expanded the sample size and performed RNA-seq analysis on a larger cohort with 14 healthy control lines and 14 schizophrenia lines after 8 weeks' differentiation ( Fig. 4a ). Again, the same subject selection criteria were employed with Caucasian males who required clozapine treatment. In addition to PCDHA2, additional 
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PCDHA genes are downregulated in schizophrenia cINs, including PCDHA3, PCDHA6 and PCDHA8 (Fig. 4b ). rtPCR analysis confirmed significant decreases of these PCDHA family members in schizophrenia cINs ( Fig. 4c ), whereas expression of PCDHA3, PCDHA6 and PCDHA8, like that of PCDHA2, was not altered in schizophrenia glutamatergic neurons ( Supplementary Fig. 8a ).
Publicly available eQTL databases (https://www.gtexportal. org and https://www.synapse.org/cmc) showed that there are many PCDHA2 eQTL SNPs with high schizophrenia association ( Supplementary Fig. 8b ), suggesting a potential role of schizophrenia risk loci in regulating expression of PCDHA2. We selected rs7445192 for genotype-gene expression correlation analysis owing to its high correlation with schizophrenia with a higher odds ratio and significant eQTL status for PCDHA2 ( Supplementary Fig. 8c ).
There was a trend of decreasing PCDHA2 expression in iPSCderived cINs with more alternate alleles of rs7445192 ( Fig. 4d ), although this did not reach statistical significance. Power analysis showed that 256 samples would be needed to reach statistical significance. Searches in the CommonMind portal showed that PCDHA2 has 533 eQTL SNPs and PCDHA3 has 0 eQTL SNPs. PCDHA6 has 88 eQTL SNPs, but rs7445192 was not one of them ( Supplementary  Fig. 8d ). Notably, we did not see genotype-expression level correlation in these two genes without a previous eQTL connection with this SNP (Fig. 4d ). PCDHA8 has 800 eQTL SNPs, including rs7445192, and also shows the tendency of decreasing expression by more alternate alleles ( Fig. 4d ), although again this finding did not reach statistical significance. Power analysis showed that 226 samples would be needed to reach statistical significance. Supplementary Table 3 . The breakdown data are summarized in Supplementary Tables 4 and 5 Supplementary Table 15 .
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NATure NeuroSCIeNCe . Red dots are significant cis-eQTLs for the given gene at false discovery rate (FDR) < 5%. More detailed information on this analysis is available in the GTEx portal (https://gtexportal.org/home/). See also Supplementary Fig. 8 . For detailed statistics information, see Supplementary Table 16 .
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In addition to PCDHA members, the majority of other protocadherin members were also downregulated in schizophrenia cINs (Fig. 4e ). rtPCR analysis confirmed significant decreases of all PCDHA and PCDHG family members in schizophrenia cINs, using primers against the PCDHA-constant region (CR) and PCDHG-CR ( Supplementary Fig. 8e ). However, expression of these genes was not altered in schizophrenia glutamatergic neurons ( Supplementary  Fig. 8f ). The publicly available eQTL databases showed that other highly affected protocadherins also had eQTL within the schizophrenia risk loci (Chr5: 140023664-140222664) a little bit further from the area where most of their eQTLs reside ( Fig. 4f and Supplementary Fig. 8g ). This suggests that this schizophrenia risk locus may be related to the regulation of multiple protocadherin family members in addition to PCDHA members.
Altered cINs and prepulse inhibition in Pcdha KO mice.
Having observed downregulation of multiple protocadherin family members, including PCDHA and PCDHG, in schizophrenia cINs, we examined the effect of protocadherin hypofunction on cIN development using a mouse model with a Pcdha null mutation (Δ α /Δ α ) 20 , in which all members of the Pcdha family are knocked out. Pcdhg is necessary for proper Pcdha localization and function 20,21 (but not vice versa). As such, Pcdhg KO mice show severe lethal phenotypes, unlike Pcdha KO mice, which show mild phenotypes. Thus, we used the partially compromised protocadherin function in Pcdha KO mice to model the protocadherin hypofunction seen in schizophrenia cINs. We analyzed the arborization of PFC cINs within 150 µ m from the cell bodies and found a mild but significant arborization deficit in Pcdha KO cINs, shown by significant decreases in neurite number from soma, total branch number and total neurite length ( Fig. 5a and Supplementary Fig. 9a ). We also observed deficits in inhibitory synapse formation of PFC cINs in Pcdha KO mice by analyzing the number of VGAT + puncta on PV + cINs that were juxtaposed with gephyrin + puncta ( Fig. 5b and Supplementary Fig. 9b ). However, there was no significant difference in the excitatory synapses that cINs receive between Pcdha KO mice and littermate wild-type controls ( Fig. 5c and Supplementary  Fig. 9c ). These results suggest the importance of protocadherin pathways in the normal development of cINs in the PFC.
Previous studies have shown that Pcdha KO mice harbor projection and connection deficits in different brain regions and display deficits in contextual learning and working memory 21 , which are relevant to the schizophrenia clinical phenotype. We tested whether Pcdha KO mice show deficits in prepulse inhibition (PPI), which occur in many schizophrenia subjects and can be attenuated by antipsychotic treatment 22 . Pcdha CR KO mice 23 , which have nonfunctional Pcdha expression, showed significant deficits in PPI compared to their wild-type littermates (Fig. 5d ). Pcdha hypomorphic mice (Δ Bneo/Δ Bneo) 24 also showed significant PPI deficits (Fig. 5e ), suggesting the importance of the protocadherin pathway for normal sensorimotor gating.
Deficits in arborization and synapses in schizophrenia cINs.
Having observed cIN deficits by protocadherin hypofunction during cIN development, we tested whether schizophrenia cINs also demonstrate similar phenotypic deficits. To analyze arborization, we infected healthy control and schizophrenia cINs with a limiting titer of lentivirus expressing GFP under the ubiquitin promoter (LV-Ubi-GFP) to label cells only scarcely. We then traced and analyzed GFP + cells. There was a mild but significant decrease in neurite number from the soma, total branch numbers and total neurite lengths in schizophrenia cINs compared to healthy control cINs (Fig. 6a ). Linear regression analysis showed that the expression levels of PCDHA2, PCDHA3, PCDHA6 and PCDHA8 were weakly or mildly correlated with arborization ( Supplementary Fig. 10a ). In the excitatory glutamatergic neuronal context, protocadherin CR inhibits focal adhesion kinase (FAK) and, in turn, PKC 25 , which otherwise inhibits arborization by inactivating MARCKS via phosphorylation 21, 25 . Thus, we tested whether treating schizophrenia cINs with PKC inhibitors can reverse this deficit through protocadherin hypofunction. Treatment with PKC inhibitor GO6893 reversed the arborization deficit in the schizophrenia cINs, whereas it did not produce a significant difference in healthy control cINs ( Fig. 6b and Supplementary Fig. 10b ). To more directly test the effect of lower protocadherin expression on cINs, we performed gene KD experiments against the PCDHA-CR or the PCDHG-CR that knock down entire PCDHA or PCDHG families ( Supplementary Fig. 10c ). Onemonth-old cINs were transfected with negative-control short interfering RNA (siRNA), PCDHA siRNA, PCDHG siRNA, or PCDHA siRNA plus PCDHG siRNA, infected with limiting titer of LV-Ubi-GFP virus, and traced at 7 d after transfection. There was a mild but significant decrease in arborization of healthy control cINs by PCDHA KD or PCDHG KD, and to a lesser degree in schizophrenia cINs ( Fig. 6c and Supplementary Fig. 10d ).
To study healthy control and schizophrenia cINs in an in vivo circuit environment, we transplanted 8-week-old cINs to the cerebral cortices of Nod Scid mice after labeling them with LV-Syn-ChR2 H134R-GFP and analyzed their phenotypes (Fig. 7a ). One of the characteristic behaviors of developing cINs is robust migration, even in transplanted adult brains; this migration comparable to their extensive migration during early development 26 . iDISCO + clearing 27 and light sheet microscopy showed robust migration of grafted cINs (Fig. 7b ) up to 2,000 µ m from the injection site in the adult mouse cortex (Fig. 7c,d) . We further characterized cINs in the brain environment with immunocytochemistry. Consistent with their MGE-derived phenotype, many grafted cINs express either MEF2C, a marker enriched in PV + interneuron precursors in mice 28 , or SST (Fig. 7e ), regardless of their disease status. We also observed that a small proportion of cINs started to express PV, regardless of their disease status ( Supplementary Fig. 11a ). Overall, these results suggest that there was no difference in cIN fate determination between healthy control and schizophrenia populations. Synapse analysis showed a mild but significant deficit in inhibitory synapse formation by schizophrenia cINs compared to healthy control cINs ( Fig. 7f and Supplementary Fig. 11b ). The excitatory synapse density did not differ between grafted healthy control cINs and schizophrenia cINs ( Fig. 7g and Supplementary Fig. 11c ). Linear regression analysis showed that the expression levels of PCDHA2, PCDHA3, PCDHA6 and PCDHA8 were weakly or mildly correlated with inhibitory synapse formation ( Supplementary Fig. 11d ). These results suggest that schizophrenia cINs have an intrinsic deficit in the formation of inhibitory synapses in the absence of a schizophrenia circuit environment. cIN deficits in schizophrenia subject postmortem brains. Having observed developmental schizophrenia cIN-intrinsic phenotypic deficits, we sought to explore whether the observed developmental deficits continue to be present in adult postmortem brains. Thus, we analyzed layer 3 PV + cINs from eight healthy control and eight schizophrenia postmortem PFCs (Fig. 8a) . Arborization analysis showed a mild but significant deficit in schizophrenia postmortem cINs that was indicated by significant decreases in neurite number from soma, total branch number and total neurite length ( Fig. 8b and Supplementary Fig. 12a ). This was consistent with the phenotypes observed in developmental cINs. A mild but significant deficit in inhibitory synapse formation was also observed in postmortem schizophrenia cINs in the PFC ( Fig. 8c and Supplementary  Fig. 12b ), also consistent with results from developmental cINs. However, unlike in the developmental schizophrenia cINs, excitatory synapse formation was significantly reduced in postmortem schizophrenia cINs ( Fig. 8d and Supplementary Fig. 12c ), possibly owing to deficits in glutamatergic neurons.
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Discussion
In this study, we find that the expression of protocadherins, genes within well-documented schizophrenia risk loci 5 Supplementary  Fig. 9 . For detailed statistics information, see Supplementary Table 17 .
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NATure NeuroSCIeNCe expression of genes within schizophrenia risk loci is important as it may shed light on the causal pathophysiology of schizophrenia. The presence of many significant eQTL SNPs for PCDHA members within schizophrenia risk loci suggests that this particular schizophrenia risk locus may regulate PCDHA gene expression. The modest change of PCDHA gene expression we observed is in agreement with the previous large-scale eQTL studies for schizophrenia risk loci 6 . Also, it is consistent with the notion that small changes in many genes may epistatically cause the disease phenotype, stressing the importance of studying 'pathway' changes instead of 'single-gene' changes to better understand schizophrenia pathogenesis. Notably, the direction of expression alterations by risk alleles is different depending on the brain regions examined, stressing the importance of using disease-relevant and homogeneous cell populations to understand the effect of the risk genotype. Supplementary Table 3 . The breakdown data for each line are summarized in Supplementary Tables 9-11 Supplementary Fig. 10 . For detailed statistics information, see Supplementary Tables 17 and 18 .
NATure NeuroSCIeNCe g f 5 μm Supplementary Table 3 . The breakdown data for each line are summarized in Supplementary Table 12 . a, Schematic diagram of transplantation analysis of healthy control versus schizophrenia cINs. 3D, three-dimensional. b, 3D lightsheet microscopy images of an iDISCO+ -cleared mouse cortex transplanted with iPSC-derived human cINs, stained with human cytoplasm antibody. Major grid in reference frame is 300 µ m. This result is from a single whole-brain staining. c,d, Recognition of grafted neurons by Imaris software, green dots. Cells in front look bigger with bigger green dots, and the cells in back look smaller with smaller green dots. Supplementary Fig. 11 . For detailed statistics information, see Supplementary Table 17 .
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Protocadherins are a family of cell surface proteins that have important roles during brain development 21 . They are transferred between the cell surface and intracellular organelles 29,30, and cell surface localization of PCDHA is facilitated by heterodimer formation with PCDHG 31, 32 . Once PCDHA is on the cell surface, oftentimes as a heterodimer with PCDHG, it inhibits the FAK-PKC pathway, which inhibits neurite arborization, thereby facilitating neuronal arborization 25, 33 . PCDHA is robustly expressed during the late embryonic to early postnatal period in axons, and then expression deceases with myelination 34, 35 , suggesting that it has a role in axonal path finding and arborization. In this study, we observed that Pcdha deficiency leads to an arborization defect in cINs in Pcdha KO mouse PFC as well as in schizophrenia cINs in vitro; this defect was reversed by inhibiting PKC downstream in the protocadherin pathway. In addition to their role in arborization, PCDHA and PCDHG proteins are localized to synapses during development 29,30,36, but not in many mature neurons 21 , suggesting that they have a role during synaptogenesis. Consistent with this inference, we observed an inhibitory presynaptic deficit in cINs both in the Pcdha-null mice PFC and in schizophrenia cINs transplanted into mouse cortex. Downregulation only in PCDHA members probably does not generate protocadherin-related phenotypes in schizophrenia cINs, considering the mild phenotype observed in Pcdha KO mice, unlike the severe lethal phenotypes of Pcdhg KO mice 37 . However, downregulation of many members of the protocadherin family, including both PCDHA and PCDHG, may explain the observed mild phenotype in schizophrenia cINs. A modestly abnormal phenotype in schizophrenia cINs is in line with the overall mild pathology of schizophrenia observed in postmortem studies.
Schizophrenia is a uniquely human disease that is not easy to model behaviorally in animals, but there are animal models in which environmental and genetic risk factors generate schizophrenia-like behaviors 38 . Schizophrenia subjects display sensory motor gating deficits, cognitive deficits and anhedonia, and these deficits can be seen in animal models of schizophrenia. Pcdha-null mutant mice have working memory deficits 21, 24 . In this study, we observed Supplementary Tables 13 and 14 . a, Table of Supplementary Fig. 12 . For detailed statistics information, see Supplementary Table 17 .
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that Pcdha-null mutant mice and Pcdha-hypomorphic mice display deficits in PPI, indicating that reduced Pcdha expression leads to impaired sensory motor gating. This behavioral deficit is consistent with the schizophrenia-like histological deficits that we observed in PFC cINs in Pcdha-null mice and suggests the role of reduced PCDHA expression in schizophrenia pathogenesis.
Previously, it was not clear whether cIN hypofunction in schizophrenia PFC was due to intrinsic defects in cINs and/or a result of hypofunction of glutamatergic input into cINs. In this study, using a homogeneous population of cINs without any schizophrenia glutamatergic input, we observed cIN-intrinsic abnormalities in vitro and in vivo. These findings demonstrate the potential of homogeneous iPSC-derived neural subtypes for unraveling disease mechanisms. In this example, the mixed cell populations used in most previous iPSC disease modeling studies 10 would not have allowed detection of cell type-specific pathological changes of minor populations. We also obtained a homogeneous population of glutamatergic neurons using Ngn2-based induction, a well-accepted protocol in the field 39 , although the induced glutamatergic neurons may not be identical to in vivo glutamatergic neurons. In addition to the homogeneity and consistency of generated cINs, the opportunity to perform extensive electrophysiological characterization gave us confidence about their authenticity and functionality. In this study, inhibitory postsynaptic currents in host cortical neurons induced by stimulation of grafted cINs were not significantly different between groups, although significant differences were detected in synapse analysis. This could be due to the small sample size of our electrophysiological experiments and/or compensatory mechanisms 40 in human cINs transplanted into normal mice brains. In the future, further technical developments that allow high-throughput analysis, such as the patch clamp array, will be pivotal to obtaining enough power to electrophysiologically study mild schizophrenia phenotypes. iPSC-derived human disease tissues can be used to screen chemicals to correct identified cellular phenotypes, thus providing unprecedented opportunities to develop mechanistic treatments. This is especially important considering that the complex genetics of schizophrenia, with over a hundred risk alleles already identified that each have only a modest effect, are difficult to replicate in experimental animals. We are not surprised that many effective treatments developed in animal models have failed in human clinical trials 41, 42 . In our study, we have observed that treatment with a PKC inhibitor corrects the abnormal cellular phenotype in schizophrenia cINs. In this regard, it is notable that a PKC inhibitor was successfully used to treat acute mania in bipolar disorders in smallscale clinical trials [43] [44] [45] , as bipolar disorder shows substantial clinical and genetic overlap with schizophrenia 46 .
Reduction in synapse density in both excitatory synapses and inhibitory synapses has been reported in schizophrenia postmortem studies 47, 48 , and the decrease in the number of inhibitory synapses in developmental schizophrenia cINs is in line with that observation. However, we observed fewer excitatory synapses in postmortem cINs, but not in developmental cINs transplanted into the mouse cortex. This can be explained if the decrease seen in human postmortem brains is due to the reduction in excitatory output from glutamatergic neurons rather than the intrinsic deficit of interneurons in receiving excitatory input. In addition, whereas numerous postmortem studies confirmed reduced GAD expression in schizophrenia interneurons, we did not see such defects in these developmental cIN populations. This discrepancy could be a consequence of comparing cells in culture with cells in vivo, or may have resulted from differences in interneuron age or subtypes. Also, it could be due to the fact that GAD expression is regulated in an activity-dependent manner 49 . Thus, rather than being an intrinsic deficit of schizophrenia interneurons, the reduction in GAD expression could have appeared only in the circuit environment with defective schizophrenia glutamatergic neurons.
In summary, the discovery of disrupted gene expression within schizophrenia risk loci, along with the animal and cell model effects, suggests the possibility of a causal relationship between protocadherins and schizophrenia. In addition, our study demonstrates the power of using homogeneous and functional populations of a specific neuronal subtype known to be affected in schizophrenia to probe the pathogenesis of schizophrenia, which may provide a pathway to identify more effective therapies and preventive interventions.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41593-018-0313-z. Skin biopsies were performed on healthy control and schizophrenia subjects. The skin tissue was cut out under local anesthesia (2% lidocaine with or without epinephrine), washed with PBS three times and placed in 35-mm culture dishes. One drop of DMEM with Glutamax with 10% FBS, 2% l-glutamine, 1% penicillinstreptomycin solution and 1% amphotericin and gentamicin solution was added on each piece of skin and put in the incubator (37 °C, 5% CO 2 ). The skin samples in the culture dishes were changed with fresh medium every other day to induce fibroblast cell growth as described 50 .
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Methods
Human fibroblasts were reprogrammed using modified RNA methods 16 by Cellular Reprogramming, Inc. (San Diego, CA). Each fibroblast line was plated in 6-well plates without feeders at three different plating densities and subjected to mRNA reprogramming. Nascent colonies were bulk passaged from the most productive well to establish passage 1 (P1) iPSC cultures on rLaminin-521 (BioLamina) in Nutristem XF medium (Biological Industries) and expanded in the same culture system until at least passage 3 before being characterized by 4′ -6-diamidino-2-phenylindole (DAPI)/OCT4/TRA-1-60 immunostaining and frozen down for storage.
Differentiation of iPSCs into cINs.
Thawed human iPSCs were maintained on Matrigel (BD) coated plates with Essential 8 (E8) medium (Invitrogen). For differentiation, iPSCs were trypsinized and grown as floating spheres in low adherent flasks in KSR medium (DMEM, 15% knockout serum replacement, 2 mM l-glutamine and 10 μ M β -mercaptoethanol (all from Invitrogen)) from day 0 to day 14. For neuroectoderm induction, cells were treated with LDN193189 (100 nM, Stemgent) from day 0 to day 14 and SB431542 (10 μ M, Tocris Cookson) from day 0 to day 7. For MGE phenotype induction, medium was supplemented with IWP2 (5 μ M, EMD Millipore) from day 0 to day 7 and SAG (0.1 μ M, EMD Millipore) from day 0 to day 21. From day 14, cells were grown in N2AA medium (DMEM-F12 with N2-supplement (1:200, Invitrogen) and 200 μ M ascorbic acid (Sigma)). FGF8 (100 ng ml -1 , Peprotech) was added from day 14 to day 21 to induce MGE phenotype at the expense of the CGE phenotype 17 . N2AA medium was supplemented with 10 ng ml -1 glial cell-derived neurotrophic factor (GDNF, Peprotech) and 10 ng ml -1 brain derived neurotrophic factor (BDNF, Peprotech) from day 21. At day 45 of differentiation, cIN spheres were trypsinized in the presence of 0.1 M trehalose (Sigma) and then plated on polyornithine (15 mg ml -1 ; Sigma)-and fibronectin (1 mg ml -1 ; Sigma)-coated plates in B27GB medium (DMEM-F12 medium with B27 supplement (1:100, Invitrogen), 10 ng ml -1 GDNF and 10 ng ml -1 BDNF). Cell lines differentiated for each experiment are summarized in Supplementary Table 3 . siRNA transfection. At day 28 of differentiation, cIN spheres were trypsinized and then plated onto polyornithine-and fibronectin-coated plates in B27GB medium. At day 2 after plating, cINs were transfected with negative-control siRNA (Ribobio), PCDHA siRNA (siG180312020039, Ribobio), PCDHG siRNA (siB180425114250, Ribobio) and PCDHA plus PCDHG siRNA (Ribobio) at a final concentration of 25 nM by using Lipofectamine RNAiMAX reagent (Life Technologies) according to the manufacturer's protocol. At 6-8 h after siRNA transfection, the cells were infected with a LV-Ubi-GFP virus, followed by arborization analysis 7 d after transfection.
Differentiation of iPSCs into glutamatergic neurons.
Human iPSC cells were seeded at a density of 10 6 cells per well on Matrigel-coated 6-well plates with E8 medium, 5 μ M Rock inhibitor Y-27632 (Selleck Chemicals), lentivirus that inducibly expressed Ngn2 and constitutively expressed puromycin resistance gene (packaged using pLV_TRET_hNgn2_UBC_Puro plasmid from Addgene, plasmid 61474 (Addgene)), 2 μ g ml -1 doxycycline and 2 μ g ml -1 polybrene. After overnight incubation (day 1), the medium was changed with N2AAGB medium (DMEMF12 with N2 supplement (1:200), 200 μ M ascorbic acid, 10 ng ml -1 GDNF and 10 ng ml -1 BDNF) with 2 μ g ml -1 doxycycline. On day 2, 1 μ g ml -1 puromycin was added to the culture. On day 3, the medium was changed with B27AAGB medium (DMEMF12 with B27 supplement (1:100), 200 μ M ascorbic acid, 10 ng ml -1 GDNF and 10 ng ml -1 BDNF) and 2 μ g ml -1 doxycycline and changed every other day until day 10. On days 11-14, the medium was replaced with B27AAGB medium without doxycycline until the neurons were harvested for RNA preparation or fixed for immunocytochemistry on day 14 of differentiation.
Immunocytochemistry, cell counting and arborization analysis. Cells were fixed in 4% paraformaldehyde for 10 min. The fixed cells were blocked in PBS with 10% normal serum and 0.1% Triton X-100 for 10 min at room temperature. Cells were incubated with the primary antibody in PBS with 2% normal serum overnight at 4 °C. After being washed in PBS, the cells were incubated with the fluorescently labeled secondary antibody in PBS with 2% normal serum for 1 h at room temperature. Cell nuclei were also counterstained with DAPI (Invitrogen, 1:10,000). We used antibodies to GAD1 (AB1511, Millipore), glutamate (G-6642, Sigma Aldrich), PV (PV 25, Swant; and PA5-47693, ThermoFisher), PSD95 (3450P, Cell Signaling), Vglut1 (73-066, UC Davis), VGAT (131 003, Synaptic Systems), gephyrin (147 011, Synaptic Systems), SOX6 (AB5805, Millipore), b-tubulin III (802001, Covance), OCT4 (CA0A3, Cell Signaling), TRA-1-60 (ab16288, Abcam), GFP (ab13970, Abcam), NCAM (sc-106, Santa Cruz Biotech), MEF2C (5030 S, Cell Signaling), SST (sc-7819, Santa Cruz Biotech), human cytoplasm (AB-121-U-050, StemCells), VIP (20077, Immunostar), CCK (C2581, Sigma Aldrich), calretinin (CG1, Swant), COUPTHII (PP-H7147-00, Perseus Proteomics), OLIG2 (AB9610, Millipore), ChAT (AB114P, Chemicon), TH (P40101-150, Pel-Freez) and 5-HT (20080, Immunostar); Information on antibodies is summarized in Supplementary  Table 1 . More information on antibody validation is in the Life Sciences Reporting Summary. After being washed in PBS, coverslips were mounted onto slide glasses using Fluoromount-G (Southern Biotech). Fluorescent images were taken using the EVOS FL Auto microscope (Life Technologies) or Olympus DSU Spinning Disc Confocal on an IX81 inverted microscope (Olympus).
For cell counting, Image J software (Version 1.51p, National Institutes of Health, NIH) was used to count the cell number using the multipoint function. The experimenters were blind to sample identification during data collection. Percentages of cells positive for each marker were quantified in relation to DAPIstained nuclei from three independent differentiations, with a total of at least 500 cells counted for each line.
For arborization analysis, cells were infected with a limiting concentration of LV-Ubi-GFP virus (multiplicity of infection = 0.001) to induce rare infections and fixed 10 d after infection for analysis. To test the effect of PKC inhibitor on arborization, we treated cell cultures with 5 μ M of GO6893 or dimethylsulfoxide as a vehicle for 12 days before fixation. GFP + cells were traced using ImageJ software version 1.51 (NIH) with the NeuronJ plug-in to obtain parameters of arborization such as neurite length, neurite number from soma, and branch number. The experimenters were blind to sample identification during data collection.
RNA preparation and real-time PCR.
RNA samples were isolated using a TRIzolreagent (Invitrogen) and 300 ng of the total RNA was used for cDNA synthesis using the Oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (Gene Link), Recombinant RNAse Inhibitor (Takara), 0.5 mM dNTP mix (Thermo Scientific), 5 mM dithiothreitol (Invitrogen), RevertAid H minus RT (Thermo Scientific), and 5× Reaction buffer (Thermo Scientific) in SimpliAmp Thermal Cycler (Applied Biosystems). The primer sequences used for rtPCR are summarized in Supplementary Table 2 . rtPCR was performed using the CFX Connect Real-Time PCR Detection system (BioRad), with 40 cycles of denaturation (95 °C for 15 s), annealing (55 °C for 30 s) and extension (72 °C for 30 s).
Whole-cell patch-clamp recordings in brain slices. For electrophysiological studies, human cINs derived from human iPSCs were infected with LV-Syn-ChR2 H134R-GFP and were transplanted as described below. At 7 months after transplantation, acute brain slices containing the cerebral cortex were prepared using a vibrating microtome (Leica Biosystems) for electrophysiological analysis. After recovery, brain slices were placed in the recording chamber and continuously perfused at the rate of 1 ml min -1 with artificial cerebrospinal fluid containing 130 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl 2 , 1 mM MgSO 4 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 and 10 mM glucose with 95% O 2 and 5% CO 2 . Wholecell patch-clamp recordings were performed at 30-32 °C using a Multiclamp 700B amplifier, a Digidata 1550A or 1320A digitizer and Clampex 10 software (Molecular Devices). For recording grafted interneurons (GFP + cells), the patch electrodes (~5 MΩ resistance) were filled with solution containing 150 mM K-gluconate, 5 mM NaCl, 1 mM MgCl 2 , 10 mM HEPES, 0.2 EGTA, 2 mM MgATP, 0.5 mM NaGTP and 5 mM biocytin (290 mosM, adjusted to pH 7.3 with KOH). For recording GFPhost cortical neurons, the patch electrodes were filled with solution containing 140 mM Cs-methanesulfonate, 5 mM NaCl, 1 mM MgCl 2 , 10 mM HEPES, 0.2 EGTA, 2 mM MgATP, 0.5 mM NaGTP, 5 mM QX 314 chloride, and 5 mM biocytin (290 mosM, adjusted to pH 7.3 with CsOH). The liquid junction potential of 15.5 and 8.9 mV was corrected for the K-gluconate-based and Cs-based pipette solutions, respectively. For experiments described in Fig. 2c , whole-cell C m was compensated with the amplifier. Series (access) resistance was not compensated.
To calculate R m and C m of grafted human interneurons in Supplementary Fig.  3b ,c, we applied hyperpolarizing voltage pulses (-5 mV) from the holding voltage of -85 mV and recorded currents in voltage-clamp mode with a sampling rate of 100 kHz in GFP + grafted cells. The peak amplitude of the transient capacitive current (I peak ) was used to estimate apparent access resistance (R a ) using the equation, R a = -5 mV/I peak . Steady-state current (I ss ) is the average current from the baseline for the last 5 ms of voltage pulse and was used to calculate R m using the equation 
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Data collection
All the traced neuronal images were taken using the EVOS FL Auto microscope (Life Technologies, Carlsbad, CA). Image J software (Version 1.51p, NIH, Bethesda, MD) was used to count the cell number using the multi point function. ImageJ software version 1.51 (NIH) with the NeuronJ plugin was used to obtain parameters of arborization. For synapse analysis, images were processed using Imaris software (Version 9.2, Bitplane, Switzerland). RNA-seq of HC and SCZ cINs were collected on Illumina NextSeq 550 system. Raw sequence reads were de-multiplexed and trimmed for adapters by using the Illumina bcl2fastq conversion software (v2. 19 ). Whole-cell patchclamp recordings were performed using a Multiclamp 700B amplifier, a Digidata 1550A or 1320A digitizer and Clampex 10 software (Molecular Devices, Sunnyvale, CA)
Data analysis
All statistical analyses were performed using GraphPad Prism7 (GraphPad Software, La Jolla, CA), SPSS (version 16; SPSS Inc., Chicago, IL) and SAS statistical software (9.4, SAS Institute, Cary, NC). Offline analysis of electrophysiological data was performed using the Clampfit 9 program (Molecular Devices). FASTQ files were aligned to the human genome (assembly hg19) using STAR and GENCODE v19 transcriptome annotation. Read pairs aligned to gene features were counted and summarized as RPKM values at the gene-level using featureCount, taking into account the strandness of the reads and all transcript variants of each gene in the GENCODE annotation. Differentially expressed genes were determined using the voom-limma package in the Bioconductor R software.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
